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Gain-of-Function Mutations in SCN11A
Cause Familial Episodic Pain
Xiang Yang Zhang,1,8 Jingmin Wen,1,8 Wei Yang,2,8 Cheng Wang,1 Luna Gao,1 Liang Hong Zheng,3
Tao Wang,4 Kaikai Ran,5 Yulei Li,1 Xiangyang Li,1 Ming Xu,1 Junyu Luo,6 Shenglei Feng,1 Xixiang Ma,1
Hongying Ma,1 Zuying Chai,3 Zhuan Zhou,3 Jing Yao,1,7,* Xue Zhang,2 and Jing Yu Liu1,*
Many ion channel genes have been associated with human genetic pain disorders. Here we report two large Chinese families with auto-
somal-dominant episodic pain. We performed a genome-wide linkage scan with microsatellite markers after excluding mutations in
three known genes (SCN9A, SCN10A, and TRPA1) that cause similar pain syndrome to our findings, and we mapped the genetic locus
to a 7.81 Mb region on chromosome 3p22.3–p21.32. By using whole-exome sequencing followed by conventional Sanger sequencing,
we identified two missense mutations in the gene encoding voltage-gated sodium channel Nav1.9 (SCN11A): c.673C>T (p.Arg225Cys)
and c.2423C>G (p.Ala808Gly) (one in each family). Each mutation showed a perfect cosegregation with the pain phenotype in the
corresponding family, and neither of themwas detected in 1,021 normal individuals. Bothmissensemutations were predicted to change
a highly conserved amino acid residue of the human Nav1.9 channel. We expressed the two SCN11A mutants in mouse dorsal root
ganglion (DRG) neurons and showed that both mutations enhanced the channel’s electrical activities and induced hyperexcitablity
of DRG neurons. Taken together, our results suggest that gain-of-function mutations in SCN11A can be causative of an autosomal-domi-
nant episodic pain disorder.Pain serves as a defense system to protect the body against
further injury and promotes healing of damaged tissues,1
but chronic pain often represents a severe and debilitating
condition.2 Up to 10% of the worldwide population is
affected with pain, and chronic pain significantly dimin-
ishes the quality of life in many affected individuals.1–4
Nociceptors detect noxious stimuli and produce the sen-
sation of pain, and such a pain-modulating signal is
conveyed to the central nervous system (CNS) by means
of action potentials.2,4 Monogenic heritable pain disorders
have provided the molecular insights into human pain
and suggested new analgesic drug targets.1,3
The voltage-sensitive sodium channels are essential for
the generation of action potentials in excitable cells.5
Sodium channels in mammals consist of an a subunit
that encodes the core protein of the channel and auxiliary
b subunits that modify the channel function.5,6 Thus far,
ten different genes (SCN1A [MIM 182389], SCN2A [MIM
182390], SCN3A [MIM 182391], SCN4A [MIM 603967],
SCN5A [MIM 600163], SCN8A [MIM 600702], SCN9A
[MIM 603415], SCN10A [MIM 604427], SCN11A [MIM
604385], and SCN7A [MIM 182392]) of a subunits
(Nav1.1–1.9 and Nax) have been identified in mam-
mals.4,5,7 Each a subunit of sodium channels consists of
four domains (DI–DIV) and each domain is composed of
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The Americanto form the voltage-sensing part of the channel, and
S5–S6 and a membrane re-entering p-loop form the chan-
nel pore.5
Gain-of-function mutations in SCN9A have been re-
ported in different painful disorders including primary
erythermalgia (PE [MIM 1330220]),8,9 paroxysmal extreme
pain disorder (PEPD [MIM 167400]),10,11 and small fiber
neuropathy (SFN [MIM 133020]).4,12 Loss-of-function
mutations in the same gene have been identified in
congenital insensitivity to pain (CIP [MIM 243000]) and
anosmia.13,14 Gain-of-function mutation in the transient
receptor potential subfamily A member 1 gene (TRPA1
[MIM 604775]) leads to familial episodic pain
syndrome.15 Recently, gain-of-function mutations in
SCN10A have been associated with painful neuropathy.12
The SCN11A is preferentially expressed in nociceptive
neurons of dorsal root ganglia (DRG) and trigeminal
ganglia.16 Similar to Nav1.8 and Nav1.5, Nav1.9 is also a
tetrodotoxin-resistant (TTX-r) channel and is activated by
relatively negative membrane potentials.17 Nav1.9
knockout mice exhibited analgesic phenotype,18,19 further
investigation in which showed that inflammatory
mediators such as formalin, carrageenan, CFA and pro-
stanoids,18 prostaglandin E2, bradykinin, interleukin-1b,
and ATP19 diminished the pain hypersensitivity. Nav1.9
is therefore a major effector of peripheral inflammatoryof Life Science and Technology and Center for Human Genome Research,
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Figure 1. Pedigree Structures, Genotypic, and Restriction Analysis in Two Chinese Families with Episodic Pain
Individuals with pain disease are indicated by solid squares (males) or solid circles (females). Unaffected individuals are indicated by open
symbols. Deceased individuals are indicated by slashes (/). The proband is indicated by an arrow.
(A)Microsatellite haplotypes spanning the linkage region on chromosome 3p22.3–p21.32 identified in the whole-genome scan from the
(legend continued on next page)
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pain hypersensitivity. Up till now, it has been unclear
whether mutations in SCN11A are associated with human
genetic pain disorders.
In this study, two Chinese families from Jilin-Tonghua
(JLTH) and Hebei-Beijing (HBBJ) with familial episodic
chronic pain were identified and characterized by the Affil-
iated Union Hospital of Huazhong University of Science
and Technology. The pain phenotype in both families
was transmitted in an autosomal-dominant pattern. The
JLTH and HBBJ families each span five generations and
include 43 and 26 members, respectively (Figures 1A
and 1C). Nine affected individuals and seven normalmem-
bers from the JLTH family and five affected individuals and
eight healthy members from the HBBJ family participated
in this study. Affected individuals from both Chinese fam-
ilies shared most common clinical features according to
their descriptions. First, the intense pain was localized
principally to the distal lower extremities and occasionally
in the upper body, especially in the joints of fingers and
arms. Second, episodic pain appeared late in the day and
relapsed once every 2–5 days for a total of 9–11 recurrences
(JLTH family) or 17–19 recurrences (HBBJ family) for one
cycle. Third, pain was exacerbated with fatigue, such as
catching a cold or performing hard exercise. The pain
was relieved by oral administration of anti-inflammatory
analgesic medicines. Fourth, the period of intense pain
usually was accompanied by sweating. The feeling of the
pain region was extremely cold and the pain could be
assuaged by a hot compress. Finally, severe pain in all
affected individuals shared the property of diminishing
with age. The clinical symptoms of the affected individuals
in both families are detailed in the Supplemental Data and
Figure S1 available online. Neurological examinations
showed that two probands retained intact sensitivities to
joint position, light touch, pin prick, etc.
After the informed consent was obtained from the par-
ticipants, peripheral blood samples were obtained from
14 affected and 15 unaffected family members and used
for isolation of genomic DNA (Figure 1). This study was
approved by the ethics committee of Huazhong University
of Science and Technology (Wuhan, China) and complied
with the Declaration of Helsinki. TRPA1, SCN9A, and
SCN10A were first sequenced in the probands of the two
families, but no pathogenic mutations were found. We
then performed a genome-wide linkage scan with 382
microsatellite markers in the JLTH family, as described
previously,20 as well as follow-up finemapping. LOD scores
for all genotypedmarkers were plotted against the physical
position of each marker in Figure 1A. Positive linkage was
identified only with markers (including D3S3623,JLTH family. Genotypes for markers D3S1277, D3S3623, D3S1298, D
symbol. The black vertical bar (including markers D3S3623, D3S129
with the disease.
(B) The NciI restriction analysis showing full segregation of the c.67
(C) Linkage analysis from the HBBJ family showed the markers D3S
D3S1581 did not.
(D) The HindIII restriction analysis showing full segregation of the c.2
The AmericanD3S1298, D3S3521, and D3S3517) on chromosome
3p22.3–p21.32. The LOD scores for the chromosome 3
markers are shown in Table S1. Two markers, D3S1298
and D3S3517, generated LOD scores greater than 3, the
cut-off LOD score for significant linkage, thereby suggest-
ing the presence of a genetic locus on chromosome 3
corresponding to the pain phenotype in the affected per-
sons under investigation (Figure 1A).
Haplotype analysis was carried out to identify the recom-
bination events in the JLTH family (Figure 1A). The
affected individuals III:3 and IV:3 showed a recombination
event between markers D3S1277 and D3S3623. The
affected individual V:6 displayed a recombination event
between markers D3S3517 and D3S3685. Taken together,
these results suggested that the gene responsible for the
pain phenotype located between D3S1277 and D3S3685
on chromosome 3p22.3–p21.32, a genomic region of
7.81 Mb (Figures 1A and 2A), which contains 55 RefSeq
genes.
Our linkage analysis and haplotyping in the HBBJ family
also suggested that the disease locus was positioned in the
same region as in the JLTH family (Figures 1C and 2A).
Two-point LOD scores for all three markers D3S1298,
D3S3521, and D3S3685 were positive (Table S1).
To identify the pathogenic mutations, genomic DNA
(3 mg) from the proband of the JLTH family was sent to
BGI for whole-exome sequencing. The genomic DNA was
randomly fragmented by the Covaris E10 system and the
size of the library fragments was distributed mainly
between 250 and 300 bp. The protein-coding regions
were captured with a Nimblegen SeqCap EZ Human
Exome Library v.2.0. High-throughput sequencing was
performed on Hiseq2000 platform. The sequences of
each individual were generated as 90 bp pair-end reads.
Clean reads were mapped onto the human reference
genome (UCSC Genome Browser hg19) with software
SOAP and BWA for SNP detection and indel detection,
respectively. Mean depth of target region was obtained
as 81.13 3 and coverage of target region as 99.54%. The
called SNPs and indels were annotated by CCDS, RefSeq,
Ensembl, and Encode databases. dbSNP (v.132) was used
to filter known variants. Protein functions of missense
SNP were predicted with SIFT. A variant (c.673C>T) in
SCN11A (RefSeq accession number NM_014139.2), which
is within the linked interval, was found. This variant is
predicted to result in an Arg to Cys substitution at amino
acid residue 225 (p.Arg225Cys) in the transmembrane
segment S4 atDI region of the Nav1.9 channel protein (Fig-
ures 2B and 2D). It is worth noting that there is a variation
(COSM108712/rs138607170) for the mutation (c.673C>T3S3521, D3S3517, D3S3685, and D3S1581 are shown below each
8, D3S3521, and D3S3517) indicates the haplotype cosegregating
3C>T mutation with the disease phenotype in the JLTH family.
1298, D3S3521, and D3S3685 cosegregating with the disease, but
423C>Gmutation with the disease phenotype in the HBBJ family.
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Figure 2. Diagram of Chromosome 3 Showing the Critical
Region and Identification of SCN11A Mutations from the JLTH
and HBBJ Families
(A) The linkage intervals and flankingmarkers of the critical region
are indicated.
(B and C) DNA sequence chromatograms showing the different
heterozygous mutations in SCN11A identified in our study
families.
(D) Schematic structure diagram of the Nav1.9 protein with a sum-
mary of pain-associated mutations.[p.Arg225Cys]) of SCN11A in Ensembl databases. Although
further analysis showed that such a variation arises because
the gene was derived from skin tumor rather than normal
tissue, it nevertheless draws our attention to the impor-
tance of using public gene databases carefully, especially
for researchers in genetics.
Further Sanger sequencing of SCN11A identified a
different missense mutation (c.2423C>G) in the proband
of the HBBJ family (the primers used are shown in Table
S4). This mutation is predicted to result in an Ala to Gly
substitution (p.Ala808Gly) in the transmembrane segment
S6 at DII region of the Nav1.9 channel protein (Figures 2C
and 2D). Because neither c.673C>T nor c.2423C>Gwould
result in a gain or a loss of a restriction site, we designed
mismatched primers to create a restriction site and used
PCR restriction fragment length polymorphism (RFLP)
assay to determine whether the twomutant alleles cosegre-
gated with the pain phenotype. The primers and restrictive
endonucleases used are listed in Table S2.
The results of the examinationof all availablemembers of
the JLTH and HBBJ families via restriction analysis showed960 The American Journal of Human Genetics 93, 957–966, Novembthat the two missense mutations fully segregated with the
pain phenotype in each of the families (Figures 1B and
1D). We also performed a screening for the mutations of
c.673C>T and c.2423C>G in 1,021 unrelated Han popula-
tions by restriction analysis, but no mutations were found
(data not shown). In addition, neither of our identified
mutations is present in either the 1000 Genomes Project
database or the National Heart, Lung, and Blood Institute
(NHLBI) Exome Sequencing Project (ESP) database.
The protein sequence alignment showed that
both Arg225 and Ala808 amino acid residues of human
Nav1.9 are highly conserved from chicken to human
(Figure S2A). Meanwhile, these two residues are also highly
conserved in different Naþ channel types, including
Nav1.1 through Nav1.9 and Nax in humans (Figure S2B).
To determine whether SCN11A mutations influence the
channel function, we assessed the biophysical properties
of human Nav1.9 (hNav1.9) mutant channels. The full-
length cDNA of the wild-type SCN11A was subcloned into
a pcDNA 3.1 (þ) expression vector, and the c.673C>T or
c.2423C>G mutant was introduced into the pcDNA 3.1-
SCN11A plasmid by site-directed mutagenesis. The primers
carrying the desired mutations are shown in Table S3. All
recombinant constructs were confirmed by restriction
enzyme digestion and verified by DNA sequencing.
The plasmids encoding wild-type, p.Arg225Cys, or
p.Ala808Gly channels were transfected into mouse dorsal
root ganglia (DRG) neurons by electroporation. The
animal protocol used in this study was approved by the
Institutional Animal Care and Use Committee of Peking
University. Primary culture of DRG neurons were prepared
as described previouslywithminormodification.21 In brief,
4- to 8-week-old adult C57male mice (~20 g) were killed by
decapitation, and DRGs together with dorsal and ventral
roots and attached spinal nerves were taken out from the
spinal column. After removing the attached nerves and sur-
rounding connective tissues, about 10–14 DRGs from
thoracic and lumbar segments of spinal cords were imme-
diately dissected and cleaned in Dulbecco’s modified
Eagle’s medium type F12 (DMEM-F12, Gibco). Ganglia
were dissociated by enzymatic treatment with collagenase
(Type IA, 1 mg/ml) and trypsin (type I, 0.3 mg/ml) at
37C for 40 min. Gentle mechanical trituration was per-
formed every 10 min through fire-polished glass pipettes
until solution became cloudy. The resulting suspension of
single cells was centrifuged, and the cell pellet was resus-
pended in 100 ml R buffer (Life Technologies). hNav1.9
(WT) or mutant constructs and EGFP were mixed at a ratio
of 10:1, and the mixture was electroporated into DRGs by
using Neon transfection system for 20 ms at 1,200 mV
twice (Life Technologies). After electroporation, cells were
seeded onto poly-L-lysine-coated coverslips and main-
tained in DMEM (Gibco) containing 10% heat-inactivated
fetal bovine serum (FBS, Gibco) and 1% penicillin/strepto-
mycin at 37C in a humidified incubator with 5% CO2.
Conventional whole-cell patch-clamp recording was
used to examine the biophysical properties of mutanter 7, 2013
hNav1.9. Patch pipettes were fabricated from borosilicate
glass with a resistance below 5 MU when filled with the
standard pipette solution. Currents were amplified with
an integrated EPC10 amplifier with Pulse software (HEKA
Elektronik, Germany). The liquid junction potential
between the pipette and bath solutions was zeroed before
seal formation. The compensation of pipette series resis-
tance and capacitance were taken by using the built-in
circuitry of the amplifier (>80%) to reduce voltage errors.
All experiments were conducted at room temperature
(22C–25C).
Patch-clamp recordings were performed 36–48 hr after
electroporation of DRG neurons. The control bath solution
contained (in mM) 140 NaCl, 5 KCl, 2 CaCl2, 10 HEPES,
0.1 CdCl2, 20 TEA-Cl, 0.001 TTX, and 10–30 glucose
(pH 7.4) (adjusted with NaOH). 20 mM tetraethylammo-
nium chloride (TEA-Cl), 0.1 mM CdCl2, and 1 mM tetrodo-
toxin (TTX) were added into the bath solution to block
endogenous voltage-gated potassium currents, calcium
currents, and TTX-sensitive sodium currents, respectively.
The standard pipette solution consisted of (in mM) 135
CsF, 10 NaCl, 2.5 MgCl2, 10 HEPES, 1 EGTA, 5 TEA-Cl,
and 4 Mg-ATP (pH 7.4) (adjusted with CsOH). Fluoride
anion was used to separate the activation and inactivation
ranges of Nav1.9 and Nav1.8.
22 For current-clamp record-
ings, the pipette solution contained (in mM) 140 KCl,
0.5 EGTA, 5 HEPES, and 2 Mg-ATP (pH 7.3) with KOH
(adjusted to 315 mOsm with dextrose). The extracellular
solution contained (in mM) 140 NaCl, 3 KCl, 2 MgCl2, 2
CaCl2, and 10 HEPES (pH 7.3) (adjusted with NaOH).
Data were analyzed with Igor software (Wavemetrics),
Clampfit (Molecular Devices), SigmaPlot (SPSS), andOrigin
(OriginLab). Activation curves were fitted to a Boltzmann
function as: G/Gmax¼ 1/(1þ exp[(V1/2 Vm)/k]), in which
Gmax is the maximal conductance, V1/2 is the half-
maximum voltage, and k is the slope factor. Steady-state
inactivation data were fitted by means of a function of
the form I/Imax¼ 1/(1þ exp[(V1/2Vm)/k]). The activation
time constants were measured by fitting the activation cur-
rents to a single exponential equation, I ¼ A$exp(t/ta) þ
C, where I is the current, A is the initial amplitude, t is
the time for activation, ta is the time constant for activa-
tion, and C is the baseline. Data were presented as
mean 5 SEM. The statistical significance of difference for
raw data was determined, when appropriate, by either Stu-
dent’s t test or one-way ANOVA followed by Dunnett mul-
tiple comparisons versus control group (SigmaPlot). p <
0.05 was considered statistically significant.
Nav1.9 channel conducts prominent persistent Na
þ cur-
rents and displays slow inactivation kinetics at relatively
depolarized potentials. Previous studies indicated that
inclusion of fluoride instead of chloride in the pipette
solution would cause a prominent negative shift in the
activation threshold of Nav1.9 but not Nav1.8, and there-
fore separated the activation ranges from each other.22
After such a performance, we examined the activation
characteristics of Naþ currents in DRG neurons expressedThe Americanwith hNav1.9 (WT), hNav1.9 (p.Arg225Cys), or hNav1.9
(p.Ala808Gly) channels in the presence of CdCl2
(0.1 mM), TEA-Cl (20 mM), and TTX (1 mM), in bath solu-
tions, and with CsF (135 mM)-based solutions as pipette
solutions. Under these conditions, Nav1.9 currents can
be recorded individually. The whole-cell currents were re-
corded from small-sized DRG neurons (<30 pF) expression
of wild-type, p.Arg225Cys, and p.Ala808Gly channels
(Figure 3A). Please note that we performed the experiments
only in the cells that displayed green fluorescence. Rela-
tively low threshold inward Naþ currents, at about
70 mV, with slow inactivation were evoked by 200 ms
test pulses ranging from 90 to 40 mV with 5 mV in-
crements. Otherwise at more positive voltages (i.e.,
>40 mV), much larger Naþ currents with fast inactiva-
tion kinetics arose, probably attributed to the activation
of another type of Naþ channels, i.e., Nav1.8 channel. As
such, we mainly analyzed the currents elicited from 90
to 50 mV. Wild-type channels and two alterations of
Nav1.9 channels produced large persistent currents, and
the voltage dependences were consistent with previous
reports.12,22 The relationship between current densities
at peak and voltages for wild-type, p.Arg225Cys, or
p.Ala808Gly channels were compared (Figure 3B). In order
to reduce the variation of current density arising from the
channel protein expression level, we took the following
experimental procedure as a strategy. In brief, after harvest-
ing the DRG neurons, we divided the cells into three por-
tions averagely and then transfected with the same
amount of plasmid either for wild-type ormutant channels
under the same electroporation conditions. In comparison
to the difference in current density for different constructs,
we conducted the electrophysiological experiments in par-
allel after establishing expression and analyzed the data
collected in the same group. As illustrated in Figure 3B,
the peak current densities for p.Arg225Cys and
p.Ala808Gly channels at 55 mV were 23% (p ¼ 0.31)
and 30% (p ¼ 0.16) larger in comparison to those of
wild-type channels, respectively. The changes of peak cur-
rent densities indicated that mutant channels,
p.Arg225Cys and p.Ala808Gly, had a higher electrical ac-
tivity than that of wild-type channels. In contrast, control
cells (n ¼ 6) transfected with empty vectors in our prepara-
tions showed very low responses displayed in hexagons.
Parameters relating to activation and inactivation for WT,
p.Arg225Cys, and p.Ala808Gly were also examined. For
evaluation of inactivation changes, we measured the
relative current for which persistent sodium currents
(measured at the end of stimulation) were normalized by
the respective maximum activation currents (the peak
amplitude for activation). Figures 3C and 3D show that
the averaged activation time constant (fit the activation
currents by a single exponential equation) and the relative
currents at different tested voltages were not significantly
different from each other. For instance, at 50 mV, ta ¼
6.46 5 0.51 ms (WT, n ¼ 18); ta ¼ 6.24 5 0.53 ms
(p.Arg225Cys, n ¼ 16); and ta ¼ 6.29 5 0.57 msJournal of Human Genetics 93, 957–966, November 7, 2013 961
Figure 3. Alterations p.Arg225Cys and p.Ala808Gly Increase Current Densities of hNav1.9 Channels and Leave Voltage Dependence
for Activation Unchanged when Overexpressed in Mouse DRG Neurons through Electroporation
(A) Representative whole-cell recordings evoked by voltage for wild-type channels (left) andmutant channels p.Arg225Cys (middle) and
p.Ala808Gly (right), respectively. Currents were elicited by 200 ms test pulses stepped from90 to40 mVwith 5 mV increments. Note
the pipette solutions contained 135mMfluoride. Vh¼120mV. The recordingwas performed at least 10min after achieving whole-cell
recording with fluoride to reduce the time-dependent shift of the parameters of current properties.
(B) Current-voltage relationships of p.Arg225Cys and p.Ala808Gly versus the wild-type for data in (A). The peak current density (normal-
ized by membrane capacitance) is plotted (n ¼ 8–15, p > 0.05). The endogenous responses from mouse DRG neurons activated by the
same voltage protocol are displayed in hexagons (6 of 16 cells). Data are presented as mean 5 SEM.
(C) Mean activation time constant fit by a single exponential equation is plotted against voltage (n ¼ 8–15). There was no significant
change for the time-to-peak values from each other (p > 0.05).
(D) Summary plot of relative current at the voltage ranging from 60 mV to 40 mV for WT and two substitutions. For the relative
currents, persistent sodium currents (measured at the end of stimulation) were normalized by the respective maximum activation cur-
rents (the peak amplitude for activation).
(E) Normalized conductance-voltage relationships. Boltzmann fits correspond to V1/2 ¼ 595 0.7 mV and k ¼ 5.15 0.5 mV for wild-
type (n¼ 16), to V1/2¼57.75 1.4mV, k¼ 5.75 0.7mV for p.Arg225Cys (n¼ 20), and to V1/2¼60.45 0.9mV, k¼ 4.85 0.6mV for
p.Ala808Gly (n ¼ 18), respectively.
(F) Steady-state inactivation curves of wild-type, p.Arg225Cys, and p.Ala808Gly are plotted. Steady-state availability data were derived by
measuring the peak current amplitude evoked by50mVafter 500ms pre-pulse to voltages ranging from120mV to 0mV. The smooth
lines are fits to a Boltzmann equation giving values of V1/2 of 57.3 5 0.7 mV, 60.6 5 0.9 mV, and 56.5 5 0.9 mV for wild-type,
p.Arg225Cys, and p.Ala808Gly, respectively (p> 0.05). All experiments in the figure were carried out in the presence of 135mMfluoride
in the pipette solutions and 1 mM TTX in the bath solutions.
962 The American Journal of Human Genetics 93, 957–966, November 7, 2013
(p.Ala808Gly, n ¼ 9). Furthermore, the conductance-
voltage curve and steady-state inactivation relationship
for wild-type, p.Arg225Cys, and p.Ala808Gly channels
were summarized in Figures 3E and 3F. As shown in
Figure 3E, solid lines fitted to a single Boltzmann equation
giving values of V1/2 ¼ 59 5 0.7 mV and k ¼ 5.1 5
0.5 mV for wild-type (n ¼ 16); V1/2 ¼ 57.7 5 1.4 mV,
k ¼ 5.7 5 0.7 mV for p.Arg225Cys (n ¼ 15); and V1/2 ¼
60.4 5 0.9 mV, k ¼ 4.8 5 0.6 mV for p.Ala808Gly (n ¼
12), respectively. In addition, Boltzmann fitting of
steady-state inactivation curve in Figure 3F corresponded
to V1/2 of 57.3 5 0.7 mV, 60.6 5 0.9 mV, and
56.5 5 0.9 mV for wild-type, p.Arg225Cys, and
p.Ala808Gly, respectively. Data were normalized with
respect to fitted values for Gmax and Imax. No significant
differences were observed from the conductance-voltage
curve and steady-state inactivation among wild-type and
p.Arg225Cys or p.Ala808Gly channels under our experi-
ment conditions. Because p.Arg225Cys is positioned in
the S4 segment of domain I where the voltage sensor is
located, a substitution of this positively charged residue
is expected to change the voltage-dependent gating of
ion channels. Extensive studies of sodium channels have
shown that substitution of the arginine residues in the
S4 segments reduces the steepness of voltage-dependent
gating. In addition, previous studies in rat brain IIA and
II sodium channels showed that the positively charged res-
idues in all four S4 segments may have an unequal contri-
bution to the voltage-dependent properties of the sodium
channel.23,24 However, the use of fluorid-based pipette so-
lution may mask some differences of voltage dependence
brought in by p.Arg225Cys because of the strong negative
shift of voltage-dependent gating of the Nav1.9 channel by
F in this study. To investigate whether the alteration of
p.Arg225Cys modifies voltage-dependent gating of
Nav1.9 channel, we also conducted similar voltage activa-
tion experiments with CsCl-based internal solution. As
illustrated in Figure S3, there was no significant change
observed from the normalized conductance-voltage rela-
tionships at the voltage ranging from 90 to 25 mV
(n ¼ 7–12). Thus, the detailed mechanism underlying the
higher current densities carried by substitutions (i.e., alter-
ations of number of channels, open probability, unitary
current, or combinations) still need further investigation.
To gain further insight into the effect of substitutions
(p.Arg225Cys and p.Ala808Gly) on excitability, we utilized
current-clamp recordings to investigate the action poten-
tial firing in DRG neurons. We injected current ranging
from 0 to 225 pA with 25 pA increments lasting for
500 ms into DRG neurons expressed with wild-type,
p.Arg225Cys, or p.Ala808Gly channels, and the represen-
tative current-clamp responses to 500 ms current pulse
injection are shown in Figure 4A. We note that the action
potential firing traces were mainly chosen to emphasize
the action potential firing frequency changes and may
not faithfully reflect the kinetics information. Statistics
data indicated that both the resting membrane potentialThe American(wild-type: 46.5 5 0.8 mV, n ¼ 40; p.Arg225Cys:
45.6 5 1.3 mV, n ¼ 20; p.Ala808Gly: 42.8 5 1.2 mV,
n ¼ 25; mock: 47.9 5 2.0 mV, n ¼ 7) and threshold
voltage at which action potential take-off occurs (wild-
type: 21.4 5 0.5 mV, n ¼ 40; p.Arg225Cys: 23.5 5
0.6 mV, n ¼ 20; p.Ala808Gly: 23.7 5 0.6 mV, n ¼ 25;
mock: 22.3 5 0.9 mV, n ¼ 7) were not significantly
different in DRG neurons expressed with wild-type
or mutant channels (Figure 4B). Both alterations
(p.Arg225Cys and p.Ala808Gly) produced an increase in
the proportion of spontaneously firing DRG neurons as
compared to that expressed with WT. Only ~10% (5 of
51 cells) of DRG neurons expressed with wild-type
Nav1.9 channels displayed spontaneous firing. In contrast,
~25% (6 of 24 cells and 7 of 28 cells for p.Arg225Cys and
p.Ala808Gly, respectively) of DRG neurons expressed
with p.Arg225Cys or p.Ala808Gly displayed spontaneous
firing, significantly more than that ofWT (p< 0.05). More-
over, averaged number of action potential firing stimulated
at 25 pA was 3.0 5 0.5, 3.8 5 0.8, and 5.6 5 0.9 for WT,
p.Arg225Cys, and p.Ala808Gly, respectively. We therefore
did not determine the current threshold for action poten-
tial generation. Action potential firing increased along
with elevation of input currents. In many but not all of
the neurons studied no matter whether they were trans-
fected with WT, p.Arg225Cys, or p.Ala808Gly, there was
a progressive diminution in the amplitude of action poten-
tials as well as the voltage of afterhyperpolarization;
furthermore, such a phenomenon varied from different
cells, even the cultured cells coming from the same cover
glass. As illustrated in Figure 4C, DRG neurons over-
expressed with hNav1.9 channels resulted in more action
potential firings as compared to that of mock transfected
cells (p < 0.05), and the averaged frequencies of action
potential firing in DRG neurons expressed with
p.Arg225Cys or p.Ala808Gly channels exhibited signifi-
cant promotion compared to that of DRG neurons
expressed with wild-type channels over a wide range of
stimuli. More importantly, DRG neurons expressed with
p.Ala808Gly fired even more action potentials than those
neurons expressed with p.Arg225Cys under the same con-
ditions (Figures 4A and 4C).
In this study, we identified two gain-of-function point
mutations in SCN11A (c.673C>T [p.Arg225Cys] and
c.2423C>G [p.Ala808Gly]) as the cause of familial episodic
pain. These substitutions are highly penetrant, similar to
TRPA1 mutation (c.2564A>G [p.Asn855Ser]), giving rise
to stereotyped episodes of severe pain.15 The difference is
that TRPA1 mutation resulted in familial episodic pain
affecting principally the upper body triggered by cold
and fasting, whereas the pain caused by SCN11A muta-
tions mainly localized to the distal lower extremities and
usually was aggravated by fatigue. Electrophysiology
experiments with isolated DRG neurons showed that
p.Arg225Cys and p.Ala808Gly alterations did increase
peak current densities and produced higher electrical activ-
ities than that of wild-type channels. Higher electricalJournal of Human Genetics 93, 957–966, November 7, 2013 963
Figure 4. Both Alterations p.Arg225Cys and p.Ala808Gly Increase the Excitability of DRG Neurons
(A) Current-clamp responses of DRGneurons expressed with wild-type, p.Arg225Cys, and p.Ala808Gly channels to 500ms current pulse
injection, respectively. Amplitude of injected current is indicated on the top of each panel.
(B) Statistics plot showing no significant changes for RMP (resting membrane potential) and Vthreshold (the threshold at which action
potential take-off occurs) from DRG neurons expressed with wild-type channels. RMP of neurons expressed with WT (46.5 5
0.8 mV, n ¼ 40), p.Arg225Cys (45.65 1.3 mV, n ¼ 20; p > 0.05), and p.Ala808Gly (42.85 1.2 mV, n ¼ 25; p > 0.05) was not signif-
icantly different. Voltage threshold of DRG neurons expressed with WT (21.45 0.5 mV, n ¼ 40), p.Arg225Cys (23.55 0.6 mV, n ¼
20; p > 0.05), and p.Ala808Gly (23.75 0.6 mV, n ¼ 25; p > 0.05) was not significantly altered, either.
(C) Comparison of averaged frequency of action potential (AP) firing (numbers of action potential firing) evoked by 500 ms current in-
jection ranging from 0 to 225 pA in DRG neurons untransfected or overexpressed with empty pcDNA3.1 vector, wild-type, p.Arg225Cys,
and p.Ala808Gly channels (*p < 0.05 as compared to wild-type).activities promoted action potential firing in DRG neurons
and might be the cause of episodic pain.
Nav1.7, Nav1.8, and Nav1.9 are preferentially expressed
in peripheral somatosensory neurons and have been impli-
cated in injury-induced neuronal hyperexcitability.25
Nav1.7 and Nav1.8 have been linked to human pain in he-964 The American Journal of Human Genetics 93, 957–966, Novembredity.8,12 Nevertheless, a direct link of Nav1.9 to human
pain has not been reported. Previous studies in Scn11a
knockoutmice have confirmed that Nav1.9 is an important
molecule in generating hyperalgesia in infammatory pain
states,18,19 suggesting that Nav1.9 channels may play an
important role in nociception.26,27 We herein provideder 7, 2013
the genetic evidence that mutations in SCN11A were
directly involved in human episodic pain. In addition,
Lolignier et al. reported that Nav1.9 channel plays an
important role in the generation of heat and mechanical
pain hypersensitivity in both subacute and chronic inflam-
matory models.28
Compared to other Nav channels, Nav1.9 generates a
persistent TTX-r current with a more hyperpolarized
voltage dependence and ultraslow recovery from inactiva-
tion in DRG neurons.19,29–31 From DRG neurons in Nav1.9
knockout mice, the persistent TTX-r current is missing and
can be restored by expression of recombinant Nav1.9 chan-
nels.18,19,29 It has been suggested that the Nav1.9 channel
is involved in the modulation of nociceptor membrane
potential and makes important contributions to establish
the membrane voltage that may in turn influence gating
of other Nav channels present in DRG neurons and overall
neuronal excitability.31,32 In contrast, Nav1.8 channels
evoked by strong depolarizations have been thought to
mediate the rapid upstroke of action potentials of sensory
neurons.32–34 Although the Nav1.9 channel is not directly
responsible for action potential generation,30,31 it may
enhance various types of firing behavior such as burst
firing and rebound firing.27,29
In the present study, we found that both mutations of
Nav1.9 channels had higher electrical activities in DRG
neurons. DRG neurons overexpressed with mutant chan-
nels also exhibited significantly augmented neuronal
action potential firing rate. Taken together, our results
suggested that the higher electrical activities of mutant
Nav1.9 channels might remarkably alter the membrane
potentials and induce the opening of other Nav channels
(such as Nav1.8 channel), and thus cause DRG neurons
to be hyperexcitable, which contributed to the familial
episodic pain disorder.
Affected individuals in the HBBJ family had many more
recurrent episodic pains than did those of the JLTH family
according to the affected persons’ description, which is
coincident with the actual fact that DRG neurons
expressed with p.Ala808Gly provoked even more action
potential firings than those expressed with p.Arg225Cys
under the same conditions.
Several studies have suggested that Nav1.9 channel
currents were upregulated by inflammatory mediators
and that the excitability of nociceptors was increased as a
result.35 Therefore, the Nav1.9 channel is thought of as
an effector of peripheral inflammatory pain hypersensitiv-
ity.27,32 Intriguingly, the pain is relieved in patients from
both Chinese families after oral administration of anti-in-
flammatory medicines (pediatric paracetamol tablets and
Fenbid capsules). It is of great interest to investigate
whether the Nav1.9 channel protein is the direct target of
these two anti-inflammatory drugs, or whether drug-regu-
lated inflammatory factors regulate the gating of Nav1.9
channels. Our above analysis provides evidence that the
Nav1.9 channel would be an appealing target for the devel-
opment of specific drugs to relieve pain.The AmericanSupplemental Data
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